CAS 201593-84-2: Bistrifluron
Formula:C16H7ClF8N2O2
InChI:InChI=1S/C16H7ClF8N2O2/c17-12-7(16(23,24)25)4-6(15(20,21)22)5-10(12)26-14(29)27-13(28)11-8(18)2-1-3-9(11)19/h1-5H,(H2,26,27,28,29)
InChI key:InChIKey=YNKFZRGTXAPYFD-UHFFFAOYSA-N
SMILES:N(C(NC(=O)C1=C(F)C=CC=C1F)=O)C2=C(Cl)C(C(F)(F)F)=CC(C(F)(F)F)=C2
Synonyms:- 1-[2-Chloro-3,5-bis(trifluoromethyl)phenyl]-3-(2,6-difluorobenzoyl)urea
- 201593-84-2
- Benzamide, N-[[[2-chloro-3,5-bis(trifluoromethyl)phenyl]amino]carbonyl]-2,6-difluoro-
- Bistrifluron
- Dbi 3204
- N-[[[2-Chloro-3,5-bis(trifluoromethyl)phenyl]amino]carbonyl]-2,6-difluorobenzamide
- N-{[2-Chlor-3,5-bis(trifluormethyl)phenyl]carbamoyl}-2,6-difluorbenzamid
Sort by
Found 8 products.
Bistrifluron 100 µg/mL in Acetonitrile
CAS:Controlled ProductFormula:C16H7ClF8N2O2Color and Shape:Single SolutionMolecular weight:446.68N-{[2-Chloro-3,5-Bis(Trifluoromethyl)Phenyl]Carbamoyl}-2,6-Difluorobenzamide
CAS:N-{[2-Chloro-3,5-bis(trifluoromethyl)phenyl]carbamoyl}-2,6-difluorobenzamide is a compound with a hydrogen bond. It has a chemical structure that can be expressed as an amide. The compound is considered to be a pharmaceutical preparation. N-{[2-Chloro-3,5-bis(trifluoromethyl)phenyl]carbamoyl}-2,6-difluorobenzamide is used in the treatment of ryanodine receptor dysfunction and human serum albumin (HSA) proteinuria. It also has been shown to have an inhibitory effect on bacterial growth and gamma aminobutyric acid (GABA) levels in the brain and to affect fatty acid metabolism. This drug has been shown to have synergistic effects when administered with piperonyl butoxideFormula:C16H7ClF8N2O2Purity:Min. 95%Molecular weight:446.68 g/mol
![N-{[2-Chloro-3,5-Bis(Trifluoromethyl)Phenyl]Carbamoyl}-2,6-Difluorobenzamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb%2FFC100005.jpg&w=3840&q=75)
